Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,000
Closed -$1.05M 1143
2022
Q2
$1.05M Sell
20,000
-20,000
-50% -$1.02M 0.04% 410
2022
Q1
$2.07M Sell
40,000
-15,000
-27% -$778K 0.07% 265
2021
Q4
$3.25M Buy
55,000
+30,000
+120% +$1.49M 0.12% 158
2021
Q3
$1.07M Buy
+25,000
New +$1.11M 0.05% 394
2020
Q4
Sell
-48,800
Closed -$1.7M 919
2020
Q3
$1.7M Sell
48,800
-10,119
-17% -$355K 0.08% 202
2020
Q2
$1.83M Buy
+58,919
New +$2M 0.1% 178

Other funds holding PFE

CSS LLC's PFE Position: Q1 2026 in Review

CSS LLC reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $134K and leaving 37,121 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #321.

CSS LLC first reported a position in PFE in Q4 2013 and has held it in 27 quarters since. The position peaked at $1.67M in Q2 2020. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CSS LLC held 37,121 shares of Pfizer worth $1.04M as of Q1 2026.
  • CSS LLC sold 5,050 Pfizer shares in Q1 2026, an estimated $134K.
  • Pfizer made up 0.05% of CSS LLC's portfolio in Q1 2026, its #321 holding.
  • CSS LLC first reported a position in Pfizer in Q4 2013 and has held it in 27 quarters since.
  • CSS LLC's Pfizer position peaked at $1.67M in Q2 2020.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.